Untreated Hairy Cell Leukemia
Progressive Hairy Cell Leukemia
Relapsed or Refractory Hairy Cell Leukemia

Untreated Hairy Cell Leukemia

If the patient's blood cell counts are not too low and there are no symptoms, treatment may not be needed and the patient is carefully watched for changes in his or her condition. If blood cell counts become too low or symptoms appear, initial treatment may include the following:

• Chemotherapy.
• Splenectomy.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with untreated hairy cell leukemia.

Treatment for progressive hairy cell leukemia may include the following:

• Chemotherapy.
• Biologic therapy.
• Splenectomy.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with progressive hairy cell leukemia, initial treatment.

Treatment of relapsed or refractory hairy cell leukemia may include the following:

• Chemotherapy.
• Biologic therapy.
• A clinical trial of stem cell transplant.
• A clinical trial of high-dose chemotherapy.
• A clinical trial of biologic therapy.

This summary section refers to specific treatments under study in clinical trials, but it may not mention every new treatment being studied. Information about ongoing clinical trials is available from the NCI Web site.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with refractory hairy cell leukemia.

Back to Top

< Previous Section  |  Next Section >